Patients undergoing transcatheter atrial septal defect (ASD) closure did not have worsening migraines after completing a course of dual antiplatelet therapy, the CANOA investigators found. Overall, ...
Three months of clopidogrel is sufficient to curb new-onset migraine headaches after percutaneous atrial septal defect (ASD) closure, new data from the randomized CANOA trial show. There was no ...
Patients being treated with dual-antiplatelet therapy (DAPT) consisting of clopidogrel plus aspirin following atrial septal defect (ASD) closure can safely discontinue clopidogrel after 3 months ...
Consultant Fee/Honoraria/Speaker's Bureau - Abbott Vascular; Siemens Healthineers Institutional Grant Support - Edwards Lifesciences; Medtronic Grant Support/Research Contract - JenaValve Receive the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results